Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

A genetically humanized mouse model for hepatitis C virus infection.

Dorner M, Horwitz JA, Robbins JB, Barry WT, Feng Q, Mu K, Jones CT, Schoggins JW, Catanese MT, Burton DR, Law M, Rice CM, Ploss A.

Nature. 2011 Jun 8;474(7350):208-11. doi: 10.1038/nature10168.

2.

Regulated Entry of Hepatitis C Virus into Hepatocytes.

Miao Z, Xie Z, Miao J, Ran J, Feng Y, Xia X.

Viruses. 2017 May 9;9(5). pii: E100. doi: 10.3390/v9050100. Review.

3.

The hepatitis C virus and its hepatic environment: a toxic but finely tuned partnership.

Perrault M, P├ęcheur EI.

Biochem J. 2009 Oct 12;423(3):303-14. doi: 10.1042/BJ20091000. Review.

PMID:
19807698
4.

How hepatitis C virus invades hepatocytes: the mystery of viral entry.

Zhu YZ, Qian XJ, Zhao P, Qi ZT.

World J Gastroenterol. 2014 Apr 7;20(13):3457-67. doi: 10.3748/wjg.v20.i13.3457. Review.

5.

Hepatitis C virus cell entry: role of lipoproteins and cellular receptors.

Burlone ME, Budkowska A.

J Gen Virol. 2009 May;90(Pt 5):1055-70. doi: 10.1099/vir.0.008300-0. Epub 2009 Mar 4. Review.

PMID:
19264629
6.

[Research on hepatitis C virus entry inhibitor].

Zeng Wenting, Lu X, Wang J, Jin X, Zhu J.

Bing Du Xue Bao. 2015 Jan;31(1):97-105. Review. Chinese.

PMID:
25997338
7.

Murine models of hepatitis C: what can we look forward to?

von Schaewen M, Ploss A.

Antiviral Res. 2014 Apr;104:15-22. doi: 10.1016/j.antiviral.2014.01.007. Epub 2014 Jan 24. Review.

8.

Primary hepatocytes as targets for hepatitis C virus replication.

Farquhar MJ, McKeating JA.

J Viral Hepat. 2008 Dec;15(12):849-54. doi: 10.1111/j.1365-2893.2008.01051.x. Review.

9.

Structural characterization of CD81-Claudin-1 hepatitis C virus receptor complexes.

Bonander N, Jamshad M, Hu K, Farquhar MJ, Stamataki Z, Balfe P, McKeating JA, Bill RM.

Biochem Soc Trans. 2011 Apr;39(2):537-40. doi: 10.1042/BST0390537. Review.

PMID:
21428935
10.

CD81-receptor associations--impact for hepatitis C virus entry and antiviral therapies.

Zona L, Tawar RG, Zeisel MB, Xiao F, Schuster C, Lupberger J, Baumert TF.

Viruses. 2014 Feb 18;6(2):875-92. doi: 10.3390/v6020875. Review.

11.

[Advancement of the study of the mechanisms of cells invades by HCV].

Zhang N, Zhang J.

Wei Sheng Yan Jiu. 2008 Jan;37(1):122-5. Review. Chinese.

PMID:
18421884
12.

Animal models for the study of HCV.

Vercauteren K, de Jong YP, Meuleman P.

Curr Opin Virol. 2015 Aug;13:67-74. doi: 10.1016/j.coviro.2015.04.009. Epub 2015 May 23. Review.

13.

Hepatitis C virus entry and neutralization.

Stamataki Z, Grove J, Balfe P, McKeating JA.

Clin Liver Dis. 2008 Aug;12(3):693-712, x. doi: 10.1016/j.cld.2008.03.008. Review.

PMID:
18625435
14.

[Progress in studies on HCV receptor of Tupaia as a potential hepatitis C animal model].

Li Y, Dai JJ, Sun XM, Xia XS.

Dongwuxue Yanjiu. 2011 Feb;32(1):97-103. doi: 10.3724/SP.J.1141.2011.01097. Review. Chinese.

15.

Hepatitis C virus entry: molecular mechanisms and targets for antiviral therapy.

Zeisel MB, Barth H, Schuster C, Baumert TF.

Front Biosci (Landmark Ed). 2009 Jan 1;14:3274-85. Review.

16.

[Interaction of hepatitis C virus with cytoplasmic membrane receptors].

Esaulenko EV, Dunaeva NV, Vetrov TA.

Vopr Virusol. 2007 Mar-Apr;52(2):4-7. Review. Russian.

PMID:
17500230
17.
18.

Hepatitis C virus host cell entry.

Ploss A, Evans MJ.

Curr Opin Virol. 2012 Feb;2(1):14-9. doi: 10.1016/j.coviro.2011.12.007. Epub 2012 Jan 4. Review.

19.

Hepatitis C virus: a new class of virus associated with particles derived from very low-density lipoproteins.

Ye J.

Arterioscler Thromb Vasc Biol. 2012 May;32(5):1099-103. doi: 10.1161/ATVBAHA.111.241448. Review.

20.

HCV animal models and liver disease.

Vercauteren K, de Jong YP, Meuleman P.

J Hepatol. 2014 Nov;61(1 Suppl):S26-33. doi: 10.1016/j.jhep.2014.07.013. Epub 2014 Nov 3. Review.

Supplemental Content

Support Center